Borui Pharmaceutical (688166.SH) issued an announcement. Recently, Borui Pharmaceutical (Suzhou) Co., Ltd., a wholly-owned subsidiary of the company...
Zhitong Finance App News, Borui Pharmaceutical (688166.SH) issued an announcement. Recently, Borui Pharmaceutical (Suzhou) Co., Ltd., a wholly-owned subsidiary of the company, received the “caprost tromethrin injection” and “drug registration certificate” issued by the State Drug Administration. Caprost and tromethotriol injections are mainly suitable for abortions between 13 and 20 weeks of pregnancy and postpartum hemorrhage caused by uterine contraction relaxation due to ineffective conventional treatment methods.